Infectious disease PCR reagents and consumables
Ended Awarded Last action
- Contract number
- 36C24822F0151
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7 Part of Abbott Laboratories
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $2,956,966
Award facts
- Contract value 100% obligated
- $2,956,965.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rosemont, IL 60018, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $463,007 | |
| Supplemental Agreement for work within scope | -$828,982 | |
| Supplemental Agreement for work within scope | -$163,270 | |
| Exercise an Option | $390,185 | |
| Supplemental Agreement for work within scope | -$160,838 | |
| Supplemental Agreement for work within scope | -$29,449 | |
| Exercise an Option | $1,094,525 | |
| Exercise an Option | $1,094,525 | |
| Supplemental Agreement for work within scope | $550,000 | |
| Original award | $547,264 |
About this award
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a delivery order valued at $2.96 million for infectious disease polymerase chain reaction (PCR) reagents and consumables under Exercise OY of a General Services Administration Schedule contract (FSS-65-VII: In-Vitro Diagnostics, Reagents, Test). The award, issued on March 14, 2022, with a completion date of September 30, 2026, carries firm fixed-price pricing and includes no small business set-aside designation. The contract supports the Veterans Integrated Service Network 8 with molecular diagnostic supplies to be delivered to Des Plaines, Illinois, consistent with Abbott Molecular's established role as a critical supplier of diagnostic testing infrastructure across the Veterans Affairs system.
This delivery order represents one component of Abbott Molecular's extensive federal contract portfolio supporting infectious disease testing capabilities across multiple VISNs and federal healthcare agencies. The company has maintained multiple blanket purchase agreements and indefinite delivery vehicles valued collectively at over $40 million with the Department of Veterans Affairs for Alinity M molecular diagnostic analyzers, reagents, and consumables used for COVID-19, HIV, hepatitis C, and human papillomavirus screening. The FSS-65-VII schedule vehicle enables streamlined procurement of specialized diagnostic reagents essential to veterans' healthcare delivery and federal pandemic response infrastructure.
Quick answers
Who was awarded contract 36C24822F0151?
36C24822F0151 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on March 14, 2022.
How much is contract 36C24822F0151 worth?
The government has obligated $2,956,966 on 36C24822F0151.
Is contract 36C24822F0151 an order under another contract?
Yes. 36C24822F0151 is a delivery order under V797D40222, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C24822F0151 competed?
The extent of competition for 36C24822F0151 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award